BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The Company plans to use the net proceeds from the offering for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Public Offering
BioSig Technologies, Inc. plans to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
- The completion of the offering is subject to market conditions, with uncertainties regarding timing, size, and terms.
- Interested parties should read the preliminary prospectus supplement and accompanying base prospectus for more information about the offering.
BioSig Technologies Inc.'s proposed public offering marks a strategic move to raise capital for its investment policy and corporate needs.